Crassoside A - Compound Card

Crassoside A

Select a section from the left sidebar

Crassoside A

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Diterpenoid
Canonical Smiles CC(=O)O[C@H]1/C(=C/CC/C(=C/CC[C@@]([C@H](C[C@H]2[C@H]1OC(=O)C2=C)O)(C)O)/C)/C
InChI InChI=1S/C22H32O6/c1-13-8-6-10-14(2)19(27-16(4)23)20-17(15(3)21(25)28-20)12-18(24)22(5,26)11-7-9-13/h9-10,17-20,24,26H,3,6-8,11-12H2,1-2,4-5H3/b13-9+,14-10+/t17-,18+,19+,20-,22-/m1/s1
InChIKey LOBTUTHTMBAWQV-RCJCYISHSA-N
Formula C22H32O6
HBA 6
HBD 2
MW 392.49
Rotatable Bonds 1
TPSA 93.06
LogP 2.98
Number Rings 2
Number Aromatic Rings 0
Heavy Atom Count 28
Formal Charge 0
Fraction CSP3 0.64
Exact Mass 392.22
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Crassocephalum mannii Asteraceae Plantae 189252

Showing of synonyms

  • Hegazy MEF, Aly AA, et al. (2008). A new 14,15-dinor-labdane glucoside from Crassocephalum mannii. Natural Product Communications,2008,3(6),869-872. [View]

No compound-protein relationship available.

Structure

SMILES: C=C1C(=O)OC(C12)CC=CCCC=CCCCCC2

Level: 0

Mol. Weight: 392.49 g/mol

Anti-inflammatory

Absorption

Caco-2 (logPapp)
-4.52
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.67
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.67

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.63
Plasma Protein Binding
55.84
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
7.4
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.47
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.49
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
5.43
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-4.92
Rat (Acute)
2.84
Rat (Chronic Oral)
2.12
Fathead Minnow
4.17
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Toxic

General Properties

Boiling Point
399.25
Hydration Free Energy
-7.62
Log(D) at pH=7.4
2.32
Log(P)
3.03
Log S
-4.09
Log(Vapor Pressure)
-7.49
Melting Point
157.44
pKa Acid
8.0
pKa Basic
4.55
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Nuclear receptor subfamily 1 group I member 2 O75469 NR1I2_HUMAN Homo sapiens 4 0.8290
Nuclear receptor subfamily 1 group I member 2 O75469 NR1I2_HUMAN Homo sapiens 4 0.8290
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Q0QF01 SDHA_PIG Sus scrofa 3 0.8128
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Q0QF01 SDHA_PIG Sus scrofa 3 0.8128
3-alpha-hydroxysteroid dehydrogenase P23457 DIDH_RAT Rattus norvegicus 3 0.8095
3-alpha-hydroxysteroid dehydrogenase P23457 DIDH_RAT Rattus norvegicus 3 0.8095
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 2 0.7918
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 2 0.7918
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 2 0.7889
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 2 0.7889
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 3 0.7793
Mycinamicin III 3''-O-methyltransferase Q49492 MYCF_MICGR Micromonospora griseorubida 3 0.7793
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7689
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7689
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 3 0.7529
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 3 0.7529
Methionine aminopeptidase 1 P53582 MAP11_HUMAN Homo sapiens 3 0.7528
Methionine aminopeptidase 1 P53582 MAP11_HUMAN Homo sapiens 3 0.7528
Corticosteroid-binding globulin P08185 CBG_HUMAN Homo sapiens 3 0.7470
Corticosteroid-binding globulin P08185 CBG_HUMAN Homo sapiens 3 0.7470
Acetylcholinesterase P21836 ACES_MOUSE Mus musculus 2 0.7409
Acetylcholinesterase P21836 ACES_MOUSE Mus musculus 2 0.7409
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.7384
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.7384
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 3 0.7358
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 3 0.7358
Nuclear receptor ROR-beta P45446 RORB_RAT Rattus norvegicus 2 0.7066
Nuclear receptor ROR-beta P45446 RORB_RAT Rattus norvegicus 2 0.7066
Soluble cytochrome b562 P0ABE7 C562_ECOLX Escherichia coli 2 0.7010
Soluble cytochrome b562 P0ABE7 C562_ECOLX Escherichia coli 2 0.7010

Download SDF